Menu
Recruiting NCT06769165

EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors

No phase Interventional Cancer Survivors

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: EMDR therapy.
Who it may be relevant to
Registry conditions: Cancer Survivors. Basic parameters: from 16 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Netherlands
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors - a Pilot Study

Overview

To explore the effectiveness of EMDR therapy treatment in reducing symptoms of chemotherapy-induced conditioned nausea and vomiting in (former) patients with cancer.

Detailed description

Conditioned nausea and vomiting is a common side effect of anti-cancer treatment, and while strategies like antiemetics exist, their effectiveness is limited. Conditioned nausea and vomiting can possibly be addressed through Eye Movement Desensitization and Reprocessing (EMDR) therapy. EMDR therapy is a therapeutic intervention, proven to be effective in the treatment of post-traumatic stress disorder (PTSD), and promising in treating a range of other conditions. At the UMCG, EMDR therapy is used on a small scale to treat conditioned nausea with positive results, although more rigorous research is needed to fully establish its efficacy. This study aims to explore the effectiveness of EMDR therapy treatment in reducing symptoms of chemotherapy-induced conditioned nausea and vomiting in (former) patients with cancer.

Interventions

  • Other EMDR therapy
    In this study, EMDR therapy will be performed by psychologists of the UMCG who are trained in EMDR therapy and who have experience with patients with somatic diseases. In the EMDR therapy protocol, the patient is guided through eight phases which incorporate dual focus of attention and alternating bilateral visual, auditory, and/or tactile stimulation (see supplement for protocol). The number of sessions varies per patient (1-3 sessions), depending on the desensitization of the conditioned stimu

Primary outcome measures

  • Degree of conditioned nausea and vomiting [Time frame: Before intake EMDR therapy session and three weeks after last EMDR therapy session]
Secondary outcome measures (1)
  • Impact on QoL of conditioned nausea and vomiting [Time frame: Before EMDR therapy]

Eligibility criteria

Inclusion criteria

  • Previously pathologically confirmed diagnosis of cancer
  • Previously treated with systemic cancer therapy
  • Persistent complaints (more than 2 months) of conditioned nausea and/or vomiting
  • Able to understand spoken and written Dutch
  • 18 years or older

Exclusion criteria

  • Ongoing psychiatric treatment
  • EMDR therapy contraindications (dissociative disorders, personality disorders or severe somatic disorders (e.g. cardiac arrhythmias))
  • Complex type 2 trauma
  • Known with recent conditions / non-anti-cancer medication which can elicit nausea (e.g. pregnancy or alcohol abuses)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Netherlands · 1 center
  • University Medical Center Groningen — Groningen

Identifiers

NCT: NCT06769165 · 19946

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗